基础医学与临床
基礎醫學與臨床
기출의학여림상
Basic & Clinical Medicine
2015年
10期
1336-1340
,共5页
樊江浩%刘揆亮%周跃%吴静
樊江浩%劉揆亮%週躍%吳靜
번강호%류규량%주약%오정
SRPX2%血管生成%细胞外基质%条件培养基
SRPX2%血管生成%細胞外基質%條件培養基
SRPX2%혈관생성%세포외기질%조건배양기
SRPX2%angiogenesis%extracellular matrix%conditioned medium
目的:评价细胞外基质蛋白含sushi重复蛋白X连锁2(SRPX2)对人脐静脉内皮细胞(HUVECs)血管生成能力的影响。方法分别用重组pcDNA3.1-SRPX2及空载质粒转染HEK293T细胞后收集条件培养基,培养HUVECs,实验分转染组、阴性对照组和空白对照组。 CCK-8试剂盒检测细胞增殖;Transwell迁移实验和划痕实验观察细胞的迁移能力;Matrigel基质胶体外管腔形成实验观察HUVECs管腔形成能力。结果3组间细胞增殖能力无明显差异。转染组管腔样结构分支点数为(97±4)个/视野,明显多于阴性对照组(57±3)和空白对照组(54±3)个/视野(P<0.05)。转染组划痕6和12 h细胞迁移距离均明显大于阴性对照组和空白对照组,分别为(90±6)、(37±7)和(36±4)μm,(135±5)、(65±8)和(63±4)μm(P<0.05)。 Transwell迁移实验中,转染组16 h迁移过膜细胞数为(549±10)个/视野,明显高于阴性对照组(334±11)和空白对照组(329±12)个/视野(P<0.05)。结论 SRPX2可通过促进HUVECs的迁移及在Matrigel表面的管腔形成能力,增强其血管生成能力。
目的:評價細胞外基質蛋白含sushi重複蛋白X連鎖2(SRPX2)對人臍靜脈內皮細胞(HUVECs)血管生成能力的影響。方法分彆用重組pcDNA3.1-SRPX2及空載質粒轉染HEK293T細胞後收集條件培養基,培養HUVECs,實驗分轉染組、陰性對照組和空白對照組。 CCK-8試劑盒檢測細胞增殖;Transwell遷移實驗和劃痕實驗觀察細胞的遷移能力;Matrigel基質膠體外管腔形成實驗觀察HUVECs管腔形成能力。結果3組間細胞增殖能力無明顯差異。轉染組管腔樣結構分支點數為(97±4)箇/視野,明顯多于陰性對照組(57±3)和空白對照組(54±3)箇/視野(P<0.05)。轉染組劃痕6和12 h細胞遷移距離均明顯大于陰性對照組和空白對照組,分彆為(90±6)、(37±7)和(36±4)μm,(135±5)、(65±8)和(63±4)μm(P<0.05)。 Transwell遷移實驗中,轉染組16 h遷移過膜細胞數為(549±10)箇/視野,明顯高于陰性對照組(334±11)和空白對照組(329±12)箇/視野(P<0.05)。結論 SRPX2可通過促進HUVECs的遷移及在Matrigel錶麵的管腔形成能力,增彊其血管生成能力。
목적:평개세포외기질단백함sushi중복단백X련쇄2(SRPX2)대인제정맥내피세포(HUVECs)혈관생성능력적영향。방법분별용중조pcDNA3.1-SRPX2급공재질립전염HEK293T세포후수집조건배양기,배양HUVECs,실험분전염조、음성대조조화공백대조조。 CCK-8시제합검측세포증식;Transwell천이실험화화흔실험관찰세포적천이능력;Matrigel기질효체외관강형성실험관찰HUVECs관강형성능력。결과3조간세포증식능력무명현차이。전염조관강양결구분지점수위(97±4)개/시야,명현다우음성대조조(57±3)화공백대조조(54±3)개/시야(P<0.05)。전염조화흔6화12 h세포천이거리균명현대우음성대조조화공백대조조,분별위(90±6)、(37±7)화(36±4)μm,(135±5)、(65±8)화(63±4)μm(P<0.05)。 Transwell천이실험중,전염조16 h천이과막세포수위(549±10)개/시야,명현고우음성대조조(334±11)화공백대조조(329±12)개/시야(P<0.05)。결론 SRPX2가통과촉진HUVECs적천이급재Matrigel표면적관강형성능력,증강기혈관생성능력。
Objective_To evaluate the proangiogenesis of extracelluar matrix proteins SRPX2 on HUVECs.Meth-ods_pcDNA3.1-SRPX2 vector ( transfection group) and pcDNA3.1 vector ( negative group) were transfected into HEK293T cells, then divided into 3 groups including blank group.The proliferation of HUVECs ( absorbance, A450 ) was detected by CCK-8 kit.The transmembrane cell number was counted by Transwell migration and wound healing assay to evaluate the migration ability of HUVECs.A three dimensional culture system of cells was construc-ted on the Matrigel, and tube formation number of HUVECs was assessed.Results_The proliferation of HUVECs ( absorbance,A450 ) among transfection group,negative group and blank group failed to show significant difference (P>0.05).A signifiant difference was noted in the total branch point of capillary tubes among transfection group, negative group and blank group[(97 ±4)/field versus (57 ±3) and (54 ±3)/field] (P<0.05).In wound healing <br> assay, the distance of transfection group compared to 0, 6 and 12 h were both significantly larger than that of nega-tive group and blank group [(90 ±6), (37 ±7),(36 ±4)μm and (135 ±5),(65 ±8),(63 ±4)μm respective-ly, both( P<0.05) ] .In Tranwell assay, the number of migrating cells in the transfection group was significantly more than negative group and blank group [(549 ±10)/field vs (334 ±11) and (329 ±12)/field(P<0.05)] af-ter co-culture 16 h.Conclusions_SRPX2 may promote angiogenesis by stimulating the migration and tubing on the Matrigel of HUVECs.